Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Bristol-Myers Squibb Company(BMY) | 685,192 | 323,358 | -361,834 | $41.79M | $14.97M | 14.86% | -$26.82M |
| KLA Corporation(KLAC) | 0 | 15,848 | +15,848 | $0 | $14.20M | 14.10% | +$14.20M |
| Corcept Therapeutics Incorporated(CORT) | 66,000 | 67,200 | +1,200 | $7.54M | $4.93M | 4.90% | -$2.61M |
| Ovintiv Inc.(OVV) | 52,200 | 107,500 | +55,300 | $2.23M | $4.09M | 4.06% | +$1.86M |
| Acadia Pharmaceuticals Inc | 263,400 | 187,800 | -75,600 | $4.38M | $4.05M | 4.02% | -$324.2K |
| Neurocrine Biosciences, Inc.(NBIX) | 30,240 | 30,940 | +700 | $3.34M | $3.89M | 3.86% | +$544.3K |
| Phreesia, Inc.(PHR) | 114,700 | 114,700 | 0 | $2.93M | $3.26M | 3.24% | +$332.6K |
| Prothena Corp PlcSHS SHS | 332,974 | 451,019 | +118,045 | $4.12M | $2.74M | 2.72% | -$1.38M |
| Protagonist Therapeutics Inc | 48,002 | 48,000 | -2 | $2.32M | $2.65M | 2.63% | +$331.6K |
| Stoke Therapeutics, Inc.(STOK) | 210,005 | 210,000 | -5 | $1.40M | $2.38M | 2.37% | +$987.0K |
| Elutia Inc.(ELUT) | 1,187,735 | 1,159,059 | -28,676 | $3.00M | $2.29M | 2.28% | -$710.0K |
| Castle Biosciences, Inc.(CSTL) | 88,404 | 110,600 | +22,196 | $1.77M | $2.26M | 2.24% | +$488.6K |
| Quidelortho Corp | 67,619 | 72,548 | +4,929 | $2.36M | $2.09M | 2.08% | -$273.8K |
| EQT Corporation(EQT) | 34,619 | 34,619 | 0 | $1.85M | $2.02M | 2.01% | +$169.3K |
| Harrow, Inc.(HROW) | 72,910 | 60,000 | -12,910 | $1.94M | $1.83M | 1.82% | -$107.0K |
| NovoCure Limited(NVCR) | 31,000 | 101,000 | +70,000 | $552.4K | $1.80M | 1.79% | +$1.25M |
| Axogen, Inc.(AXGN) | 161,000 | 161,000 | 0 | $2.98M | $1.75M | 1.73% | -$1.23M |
| Biodesix, Inc.(BDSX) | 5,736,113 | 5,736,113 | 0 | $3.59M | $1.62M | 1.61% | -$1.97M |
| Travere Therapeutics, Inc.(TVTX) | 138,000 | 103,000 | -35,000 | $2.47M | $1.52M | 1.51% | -$948.6K |
| Foghorn Therapeutics Inc.(FHTX) | 310,930 | 310,930 | 0 | $1.13M | $1.46M | 1.45% | +$326.5K |
| Alkermes plcSHS(ALKS) | 50,000 | 50,000 | 0 | $1.65M | $1.43M | 1.42% | -$220.5K |
| Masimo Corp | 11,280 | 8,280 | -3,000 | $1.88M | $1.39M | 1.38% | -$486.4K |
| uniQure N.V.SHS(QURE) | 88,697 | 98,697 | +10,000 | $940.2K | $1.38M | 1.37% | +$435.6K |
| United Therapeutics Corporation(UTHR) | 7,500 | 4,250 | -3,250 | $2.31M | $1.22M | 1.21% | -$1.09M |
| DocGo Inc.(DCGO) | 864,062 | 764,062 | -100,000 | $2.28M | $1.20M | 1.19% | -$1.08M |
| Treace Medical Concepts, Inc.(TMCI) | 164,947 | 176,947 | +12,000 | $1.38M | $1.04M | 1.03% | -$343.5K |
| Solid Biosciences Inc | 128,768 | 178,768 | +50,000 | $476.4K | $870.6K | 0.86% | +$394.2K |
| Kiniksa Pharmaceuticals Ltd | 30,006 | 30,000 | -6 | $666.4K | $830.1K | 0.82% | +$163.7K |
| Freeport-McMoRan Inc.CL B(FCX) | 0 | 18,033 | +18,033 | $0 | $781.7K | 0.78% | +$781.7K |
| Kalvista Pharmaceuticals Inc | 67,002 | 67,000 | -2 | $773.2K | $757.4K | 0.75% | -$15.8K |
| Structure Therapeutics IncADR | 0 | 36,000 | +36,000 | $0 | $746.6K | 0.74% | +$746.6K |
| Apogee Therapeutics Inc | 8,000 | 16,000 | +8,000 | $298.9K | $694.9K | 0.69% | +$396.0K |
| Outset Medical, Inc.(OM) | 24,584 | 34,584 | +10,000 | $271.9K | $664.4K | 0.66% | +$392.5K |
| Xenon Pharmaceuticals Inc.(XENE) | 21,000 | 21,000 | 0 | $704.5K | $657.3K | 0.65% | -$47.3K |
| Ultragenyx Pharmaceutical Inc.(RARE) | 16,000 | 18,000 | +2,000 | $579.4K | $654.5K | 0.65% | +$75.1K |
| Axsome Therapeutics, Inc.(AXSM) | 6,000 | 6,000 | 0 | $699.8K | $626.3K | 0.62% | -$73.4K |
| Olema Pharmaceuticals, Inc.(OLMA) | 0 | 134,000 | +134,000 | $0 | $570.8K | 0.57% | +$570.8K |
| Scholar Rock Holding Corporation(SRRK) | 16,000 | 16,000 | 0 | $514.4K | $566.7K | 0.56% | +$52.3K |
| Intellia Therapeutics, Inc.(NTLA) | 0 | 60,000 | +60,000 | $0 | $562.8K | 0.56% | +$562.8K |
| OrthoPediatrics Corp.(KIDS) | 20,000 | 26,000 | +6,000 | $492.6K | $558.5K | 0.55% | +$65.9K |
| Immunome, Inc.(IMNM) | 0 | 60,000 | +60,000 | $0 | $558.0K | 0.55% | +$558.0K |
| Xencor, Inc.(XNCR) | 26,000 | 70,000 | +44,000 | $276.6K | $550.2K | 0.55% | +$273.6K |
| Halozyme Therapeutics, Inc.(HALO) | 10,000 | 10,000 | 0 | $638.1K | $520.2K | 0.52% | -$117.9K |
| Pacific Biosciences of California, Inc.(PACB) | 0 | 400,000 | +400,000 | $0 | $496.0K | 0.49% | +$496.0K |
| Inhibrx Biosciences, Inc.(INBX) | 32,110 | 32,110 | 0 | $449.2K | $458.2K | 0.46% | +$9.0K |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 8,000 | 8,000 | 0 | $312.6K | $377.6K | 0.37% | +$65.0K |
| Alphatec Holdings, Inc.(ATEC) | 33,000 | 33,000 | 0 | $334.6K | $366.3K | 0.36% | +$31.7K |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 40,000 | 40,000 | 0 | $300.0K | $358.4K | 0.36% | +$58.4K |
| Blueprint Medicines Corp | 2,700 | 2,700 | 0 | $239.0K | $346.1K | 0.34% | +$107.1K |
| Cytokinetics, Incorporated(CYTK) | 10,000 | 10,000 | 0 | $401.9K | $330.4K | 0.33% | -$71.5K |
| Candel Therapeutics, Inc.(CADL) | 60,000 | 60,000 | 0 | $339.0K | $303.6K | 0.30% | -$35.4K |
| TELA Bio, Inc.(TELA) | 155,000 | 155,000 | 0 | $189.1K | $300.7K | 0.30% | +$111.6K |
| Cogent Biosciences, Inc.(COGT) | 0 | 40,000 | +40,000 | $0 | $287.2K | 0.29% | +$287.2K |
| Wave Life Sciences, Inc.SHS(WVE) | 40,300 | 40,300 | 0 | $325.6K | $261.9K | 0.26% | -$63.7K |
| 10x Genomics, Inc.CL A(TXG) | 50,000 | 22,000 | -28,000 | $436.5K | $254.8K | 0.25% | -$181.7K |
| Apellis Pharmaceuticals Inc COM | 14,000 | 14,000 | 0 | $306.2K | $242.3K | 0.24% | -$63.8K |
| Phathom Pharmaceuticals, Inc.(PHAT) | 0 | 25,000 | +25,000 | $0 | $239.8K | 0.24% | +$239.8K |
| BridgeBio Pharma, Inc.(BBIO) | 0 | 5,000 | +5,000 | $0 | $215.9K | 0.21% | +$215.9K |
| NeuroPace, Inc.(NPCE) | 16,442 | 16,442 | 0 | $202.1K | $183.2K | 0.18% | -$18.9K |
| Gossamer Bio, Inc.(GOSS) | 138,176 | 138,176 | 0 | $152.0K | $170.0K | 0.17% | +$18.0K |
| Amicus Therapeutics Inc COM | 28,000 | 28,000 | 0 | $228.5K | $160.4K | 0.16% | -$68.0K |
| Zenas BioPharma, Inc.(ZBIO) | 16,500 | 16,500 | 0 | $130.3K | $159.9K | 0.16% | +$29.5K |
| Cullinan Therapeutics, Inc.(CGEM) | 20,000 | 20,000 | 0 | $151.4K | $150.6K | 0.15% | -$800 |
| Karyopharm Therapeutics Inc.(KPTI) | 27,985 | 27,985 | 0 | $104.7K | $120.6K | 0.12% | +$16.0K |
| Applied Therapeutics Inc | 0 | 280,000 | +280,000 | $0 | $87.1K | 0.09% | +$87.1K |
| Ventyx Biosciences Inc | 28,800 | 28,800 | 0 | $33.1K | $61.6K | 0.06% | +$28.5K |
| InflaRx N.V.(IFRX) | 50,000 | 50,000 | 0 | $51.0K | $39.5K | 0.04% | -$11.5K |
| Aptevo Therapeutics Inc | 0 | 10,000 | +10,000 | $0 | $30.5K | 0.03% | +$30.5K |
| Alumis Inc | 10,000 | 10,000 | 0 | $61.4K | $30.0K | 0.03% | -$31.4K |
| Zentalis Pharmaceuticals, Inc.(ZNTL) | 17,000 | 17,000 | 0 | $27.0K | $19.7K | 0.02% | -$7.3K |
| Accelerate Diagnostics Inc | 325,239 | 325,239 | 0 | $228.0K | $2.1K | 0.00% | -$225.9K |
| 2seventy Bio Inc | 15,500 | 0 | -15,500 | $76.6K | $0 | — | -$76.6K |
| Arvinas, Inc.(ARVN) | 30,000 | 0 | -30,000 | $210.6K | $0 | — | -$210.6K |
| Atara Biotherapeutics Inc | 22,000 | 0 | -22,000 | $130.7K | $0 | — | -$130.7K |
| Compass Therapeutics, Inc.(CMPX) | 24,000 | 0 | -24,000 | $45.6K | $0 | — | -$45.6K |
| Direxion Daily Pharmaceutical & Medical Bull 3x ShDLY TECH BULL 3X DA TE BU 3X ETF | 20,000 | 0 | -20,000 | $144.4K | $0 | — | -$144.4K |
| Keros Therapeutics, Inc.(KROS) | 15,000 | 0 | -15,000 | $152.8K | $0 | — | -$152.8K |
| Liquidia Corporation(LQDA) | 10,013 | 0 | -10,013 | $147.7K | $0 | — | -$147.7K |
| Pulmonx Corporation(LUNG) | 51,000 | 0 | -51,000 | $343.2K | $0 | — | -$343.2K |
| Springworks Therapeutics Inc | 8,280 | 0 | -8,280 | $365.4K | $0 | — | -$365.4K |